CAMBRIDGE, Mass., Oct. 4, 2018 /PRNewswire-iReach/ — rHEALTH LLC, an innovative digital health solutions company, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/645,388, entitled “Sample Consumable and Loader” filed by its affiliate company, DNA Medicine Institute (DMI). This application covers the consumable that carries a microvolume of sample to a sample loader to increase reproducibility of sample loading and offers ease-of-use. A Notice of Allowance is a written notification from USPTO that review of the patent application has completed and issuance of the patent is pending. rHEALTH expects the patent to be issued within two months.
“This Notice of Allowance is an important milestone as we continue to execute against our patent strategy in our effort to develop better care through innovation in portable diagnostic and monitoring technologies”, said Dr. Eugene Y. Chan, Founder and CEO. “The fundamental aspects of this patent enable our consumable technology that carries a small volume of sample possible at point-of-care.”
About rHEALTH
rHEALTH is an innovative digital health solutions company focused on creating integrated technologies that fundamentally change how we care for our health. rHEALTH’s innovations consists of the rHEALTH diagnostic platform, which enables diverse laboratory test classes in a single small volume blood sample intended as a point-of-care solution, the SKYE Sensor, a wireless wearable providing comprehensive real-time vitals monitoring and CHAS, a user-friendly mobile application. For more information, visit www.rhealth.com.
About DNA Medicine Institute
rHEALTH’s affiliate, DNA Medicine Institute (DMI) is a biomedical incubator focused on advancing patient care, alleviating human suffering, and treating disease through innovation. Its work is supported by NASA, National Institutes of Health, and the Bill & Melinda Gates Foundation. DMI leverages substantial expertise in interdisciplinary science and engineering to solve challenging problems. For more information, visit www.dnamedinstitute.com.
Media Contact
John Adamou
Vice President, Corporate and Business Development and Media Relations
(617) 999-8395
pr@rhealth.com
